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INTRODUCTION
Psoriasis is a persistent relapsing papulosquamous disease
of the skin, and is characterized by an aberrant differentiation
and hyperproliferation of keratinocytes. Genetic susceptibil-
ity and environmental factors such as physical trauma, infec-
tion, psychological stress, or drugs contribute to the devel-
opment of psoriasis (1). In relation to a hereditary tendency,
family studies have shown that the incidence of psoriasis is
higher among relatives and offspring of the affected proband
and a concordant occurrence of psoriasis is observed among
monozygotic twins (1-4). Linkage disequilibrium studies have
reported psoriasis-associated genetic loci within the major
histocompatibility complex (MHC) (5) and chromosome 4q
(6) and 17q (7).
In addition to a hereditary tendency, genetic alterations such
as a chromosomal loss in a somatic cell have been observed
frequently in the previous study of psoriatic lesions (8). Since
studies of colorectal cancer reported multiple chromosomal
losses on the basis of the loss of heterozygosity (LOH) detected
by the polymorphic markers (9, 10), malignant outgrowth
disorders of the skin including basal cell carcinoma (11), squa-
mous carcinoma (12), and malignant melanoma (13) were
also reported to harbor a LOH on multiple chromosomes.
PCR-based microsatellite analysis, which requires only a small
sample of DNA for a number of genetic markers (14), has
indicated the presence of LOH in a variety of cell proliferat-
ing disorders, supporting the hypothesis that the inactivation
of the regulatory genes caused by a LOH results in hyper-
proliferation and abnormal differentiation of keratinocytes
(8). However, chromosomal losses are unlikely to be respon-
sible for the symmetric psoriatic plaques of the common type.
This is because such acquired genetic alterations conferring
a selective growth advantage are more likely to contribute to
a segmental plaque manifestation resulting from the clonal
expansion of a disordered single cell (15). Therefore, there is
some debate as to whether or not multiple LOH events truly
exist in psoriasis.
Although PCR-based LOH analysis has been widely used
over the past decade to investigate chromosomal losses, there
appear to be contrasting results among the individual stud-
ies on the incidence and pattern of chromosomal loss occur-
ring in a given cell proliferation disorder (16). Sampling of
genomic DNA and the unstable natures of the microsatel-
lite markers are known to be the two major causes of PCR
artifacts giving a rise to false-positive and -negative results in
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Loss of Heterozygosity and PCR Artifacts in a Microsatellite Analysis
of Psoriasis and Colorectal Cancer
Although a loss of heterozygosity (LOH) is commonly observed using microsatel-
lite markers in a cell-proliferating malignant disorder, controversial findings of pso-
riasis, a keratinocyte-outgrowth disease, remain to be explained. It was hypothe-
sized that unstable natures of the microsatellite markers for the polymerase chain
reaction (PCR) might give a rise to either a false-positive or -negative LOH. Twenty-
one frozen skin tissues and 33 formalin-fixed paraffin-embedded archives were
obtained from patients with psoriatic plaques and colorectal cancers, respective-
ly. In the frozen psoriatic skin, two of the 17 microsatellite markers selected from
11 chromosomal arms were associated with artifact LOHs that were not repro-
duced in repeated PCRs. The remaining 15 stable microsatellite markers with
few PCR artifacts demonstrated a borderline-level LOH in cases with an ambigu-
ous heterozygosity such as a juxtaposed allelic band. Infrequent LOHs (3 out of
242 heterozygous markers, 1.2%) were detected in psoriatic cases with two sepa-
rate alleles. In colorectal cancers, a set of the 15 stable microsatellite markers
identified a minimal borderline-level LOH at the cut-off point that was same with
that of psoriasis. These results indicate that the selection of reproducible micro-
satellite sequences and the cautious criteria for informative heterozygosity are re-
quired to obtain the reliable LOH results from variable genomic DNAs, and that
psoriatic lesions harbor few LOH. 
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a LOH diagnosis (16, 17). Genomic DNA extracted from
formalin-fixed, paraffin-embedded tissue is highly fragment-
ed and cross-linked, and are sometimes prone to artificial
PCR amplification (16, 17). A set of PCR primers encom-
passing microsatellite repetitive sequences are superimposed
to the erroneous products because a slippage in the repeat
units commonly results in a stutter or satellite extra-ladder
bands (18).
The reliability of PCR-based LOH analysis was examined
using stable microsatellite markers that were expected to con-
fer the unequivocal microsatellite amplification in the genom-
ic DNA from both the formalin-fixed paraffin-embedded
colorectal cancer tissue (poor quality DNA) and frozen pso-
riatic skin tissue (intact DNA). The microsatellite markers
were selected from 11 chromosomal arms, 3p, 4p, 4q, 5q,
7p, 8p, 9p, 11p, 13q, 17p and 18q, which are known to suf-
fer from frequent LOH in colorectal cancer and/or psoriasis
(8, 19). A set of stable microsatellite markers showing a few
PCR artifacts proved that the loss of a total or extensive chro-
mosomal arm, rather than an interstitial region, was a major
event in malignant lesions, but not in psoriatic lesions.
MATERIALS AND METHODS
Biological material and DNA extraction
Twenty-one psoriatic patients were selected by reviewing
the medical records from the Uijongbu St. Mary’s Hospital
of the Catholic University of korea and were enrolled accord-
ing to the amount of available skin sample. Psoriatic epider-
mal samples were obtained from 3-mm punch biopsies that
were digested using dispase (Boehringer Mannheim Co., Indi-
anapolis, IN, U.S.A.). Matched blood samples were used as
the negative controls. The genomic DNA was extracted from
the blood and tissue of psoriasis patients with a QIAamp DNA
Minikit according to the manufacturer’s instructions (Qiagen
Inc., Catsworth, CA, U.S.A.).
Formalin-fixed, paraffin-embedded colorectal carcinoma
tissue was obtained from surgical resections conducted from
1995 to 1999. Seven-micrometer sections were stained with
hematoxylin-eosin, and the tumor-rich areas representative
of the histological features were then chosen by a microscop-
ic examination. Normal tissues in the tumor portions were
manually removed from the slides by a scalpel under stereo-
microscopic guidance (Fig. 1). For each case, approximately
100 microdissected cells were digested with 1  L of Tween
20-Proteinase K lysis buffer. The lysate mixtures were used
as the genomic DNA for PCR analysis.
Microsatellite analysis
For the PCR-based LOH analysis, 27 primer pairs of the
microsatellte loci were obtained from Research Genetics
(Huntsville, AL, U.S.A.) on chromosome 3p, 4p, 4q, 5q, 7p,
8p, 9p, 11p, 13q, 17p, and 18q (Table 1). The allelic frequen-
cy and PCR product size were from the Genome Database
(http://www.gdb.org/). Each PCR was initiated at the so-
called hot-start condition by heating the template-primer
mixtures containing 1  L of the tissue lysate or the extracted
DNA template and 5  M of the sense and antisense primers
for 5 min at 95℃. A 5- L solution of the reaction mixture
including 0.1  L dNTP (1.25 mM mixture of dATP, dCTP,
dGTP, and dTTP, Boehringer Mannheim Biochemicals, Indi-
anapolis, IN, U.S.A.), 1  L of a 10×reaction buffer, 0.6  L
of 25 mM MgCl2, 1 U Taq DNA polymerase (Promega, Ma-
dison, WI, U.S.A.), and 0.5  Ci [ -32P]dCTP (3,000 Ci/
mmol, Amersham Pharmacia Biotech, Sweden) were added
to the template-primer mixture at 95℃. PCR was carried
out using an MJR gene cycler (MJ Research Co., Waltham,
MA, U.S.A.) in 32 amplification cycles; 94℃ for 50 sec, an
annealing temperature 55-62℃ for 50 sec, and 72℃ for 1
Fig. 1. Manual microdissection from formalin-fixed paraffin-embedded tissues on a microscopic slide (H&E,×40). Admixtures of normal
stroma and tumor tissue (A) were manually scrapping off the stromal tissue under the stereomicroscopic guidance (B). The tumor cell
content was found to be >70 % to obtain pure tumor DNA, which represented the true allelic status of the tumor.
A Bmin. No additional PCR cycles were performed in order to
avoid over-amplification leading to PCR artifacts. Two micro-
liters of the PCR products were diluted with 5  L of a for-
mamide-dye loading buffer, heated at 80℃ for 3 min, and
electrophoresed on 6% polyacrylamide gel containing 7 M
urea. The radioisotope-labeled microsatellite bands were visu-
alized by an autoradiogragh of denaturing gel electrophoresis.
Repeated exposures of each autoradiograph were performed
to obtain an optimal range of the allelic band intensities for
densitometric analysis.
Analysis of microsatellite alleles
The highly heterogeneous patterns of the microsatellite
sequences amplified by PCR were converted into one-dimen-
sional peaks to standardize the LOH scores with the use of
the “profile” option in TINA (raytest Isotopenme gerate
GmbH, Straubenhardt, Germany) image software (Fig. 2).
In the heterozygous cases, the diverse peaks including both
main and shadow bands were divided into two compartments
for a single allelic intensity. In the cases with the two alleles
in proximity, where excessive shadow bands co-migrate, the
overlapping peaks were subtracted from the allelic intensity
measurement.
The difference in the allelic intensity between the normal
and lesion DNAs was scored as the relative allelic ratio cal-
culated by dividing the intensity ratio of the lesion by the
normal allelic ratio. If gain of allele were found in the lesion
DNA, they were interpreted as a microsatellite instability,
which were not included in LOH analysis.
RESULTS
Microsatellite allelic signals in frozen psoriatic tissue
Of the 21 psoriasis patients examined, 10 (47%) and 11
(53%) were females and males, respectively. Seventeen pa-
tients (81%) were afflicted with early onset psoriasis before
they were 40 yr-old, of which 8 (47%) had a family history.
The remaining 4 patients suffered from a late onset of the
disease without a family history. The psoriatic epidermal
tissue separated from the dermis by a dispase digestion of
the punch-biopsy sample was found to harbor non-epider-
mal cells <20%, such as inflammatory cells.
Because of a limited amount of genomic DNA from the
punch-biopsy skin, 21 paired genomic DNAs were initially
examined for LOH using a total of 17 microsatellite mark-
ers from 11 chromosomal arms, 3p, 4p, 4q, 5q, 7p, 8p, 9p,
11p, 13q, 17p, and 18q. The intensity ratios of most of the
heterozygous psoriatic lesions relative to that of blood DNA,
i.e., the difference in the allelic signals between the normal
and lesional DNAs, clustered less than 1.5 fold representing
the baseline level of PCR noise. Psoriatic lesions with a rela-
tive allelic ratio greater than 1.5 fold were observed in the
markers on chromosome 3p, 8p, and 9p, D3S1478, ANK1,
D8S7, D9S157, and D9S199, which is indicative of the allel-
ic imbalance responsible for the LOH. Of the markers asso-
ciated with frequent LOHs, the ANK1 and D8S7 markers
showed up as ghost bands, which may not have been repro-
duced in repeated PCRs. Ghost bands were considered to be
nonspecific findings with genomic sequence redundancy, sub-
optimal PCR condition, or unstable nature of microsatellite
marker (Fig. 2).
The heterozygous cases with separate alleles exhibited sta-
ble allelic ratios, whereas the heterozygous cases with over-
lapped allelic bands revealed a borderline level of a relative
allelic ratio. When two intimate allelic bands differed in size
by one repeat unit, such as in cases 10 (1.54) and 16 (1.50),
the D9S199 markers were scored as being a borderline LOH
(Fig. 2). To improve the feasibility of the allelic imbalance,
two alleles differing in size by more than one repeat unit were
defined as the informative case for LOH analysis. 
PCR noise and artifacts in intact and poor quality DNAs
Of the 11 chromosomal arms examined, 3p, 8p, and 9p
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3p D3S1298 194-220 24.2-22 52.4 0
D3S1478 109-152 21.3-21.2 60 8.3
D3S1597 80-100 24.2 73.3 0
D3S1611 277-288 24.2-22 40 0
4p D4S391 165-185 15.1 53.3 0
4q FGA 199 28 66.7 0
5q D5S346 96-122 22-21 60 0
D5S299 156-182 15-22 53.3 0
6p D6S105 138-168 21.1-21.33 80 0
7p D7S519 256-268 15-22 42.9 0
8p ANK1 332 12-11.2 NI
� NI
�
D8S7 250-252 23 NI
� NI
�
D8S261 128-144 22 53 0
D8S262 114-128 23 73 0
D8S503 240 22 50 0
D8S552 180 22 40 0
D8S1734 100-120 22-21.3 53 0
9p D9S157 133-149 23-22 93 14
D9S199 144-164 23 67 20
D9S200 107-127 21-12 73 0
D9S270 97 21 73 0
D9S288 120-140 pter-p22 60 0
11p D11S861 154 15.2 87 0
13q D13S263 149 14 60 0
17p D17S1566 179-209 13.3 53 0
D17S796 144-174 13.2 53 0
18q D18S67 113-129 12.2-12.3 43 0
Chromo-
some
Marker Size  (bp) Location
LOH*
(%)
Table 1. Microsatellite markers used for LOH detection in pso-
riasis (N=21)
Hetero-
zygosity (%) 
*LOH: Loss of heterozygosity; 
� NI: noninformative PCR artifacts.
. .showing a LOH or LOH artifacts were further examined in
the psoriatic lesions and colorectal cancers to compare the
relative allelic ratios between the frozen skin tissue (intact
DNA) and the formalin-fixed tissue (poor quality DNA).
The additional markers on the three chromosomal arms,
D3S1597, D3S1611, D8S261, D8S262, D8S503, D8S552,
D8S1734, D9S200, D9S270, and D9S288 were used in the
15 psoriatic lesions and 33 colorectal cancers because of the
small DNA amounts. There were 242 and 275 informative
heterozygous markers in the psoriasis and colorectal cancer
patients, respectively.
Of the 242 heterozygous markers from the psoriatic DNAs
with two separate alleles, 239 (99%) demonstrated balanced
allelic ratios distributed in a narrow range of <1.50 (Fig. 3).
The remaining 3 markers were defined as being LOH-posi-
tive based on the relative allelic ratio values, 1.57 (case 10),
1.51 (case 12), and 1.92 (case 16), which were indicative of
the diminished upper allelic signals (Fig. 2). The infrequent
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D9S200
Relative allelic ratio = 1.09
NP N P
Fig. 2. Measurement of the difference in the allelic intensity between psoriatic DNA (P) and normal DNA (N). The allelic ratio of psoriatic
DNA relative to that of normal DNA is shown below the paired lanes. A peak area including both the main and shadow bands was mea-
sured for a single allelic intensity. As shown in D9S200 marker, typical heterozygosity exhibits two separate allelic bands accompanying
the satellite bands. In D9S270 marker, the cases with two alleles in proximity where the shadow bands from both alleles co-migrated, the
overlapping peaks (open area) were subtracted from the allelic intensity measurements. Both the ANK1 and D8S7 markers show allelic
band artifacts (indicated by arrows) that were not observed in other PCRs. Borderline-level LOHs in juxtaposed heterozygous alleles at
D9S199 were due to the excessive co-migration of the main and satellite bands between the two alleles. Three cases (cases 10, 12 and
16) with diminished upper alleles at D3S1478 and D9S157 appeared to be caused by equivocal amplifications of the upper and low alleles.
D9S199
NP NP
Case 10
1.54 1.50 1.57 1.51 1.92
Case 16
D9S157
NP NP
Case 12 Case 16
D3S1478
NP
Case 10
ANK1
NPNPNPNP NPNPNPNP
D8S7
NPNPNPNP NPNPNPNP
D9S270
Relative allelic ratio = 1.28
NP N Pupper allelic losses were unlikely to represent unilateral chro-
mosomal loss, because the upper alleleic signals tended to be
equivocally diminished in relation to the lower allele, result-
ing in false-positive LOH (Fig. 2). The colorectal cancer DNAs
demonstrated a broad range of relative allelic ratios, includ-
ing high-level allelic imbalances greater than 1.5 fold, which
similarly occurred at both the upper and lower alleles (Fig. 3).
Especially, a set of the stable microsatellite markers identi-
fied a few borderline-level allelic ratios (1.8%, 5 of 275 in-
formative markers) ranging from 1.5 to 1.6. These findings
suggest that the stable marker set provided the reliable LOH
results from variable genomic DNAs and that infrequent
upper allelic loss in psoriatic lesions is most likely to be a
false-positive LOH (Table 2).
DISCUSSION
The initial LOH studies on colorectal cancer suggest a
genetic mechanism that underlies tumorigenesis through
the inactivation of the tumor suppressor genes (19). Since
the initial colorectal cancer studies employed genomic DNA
hybridization with restriction fragment length polymorphism
(RFLP) probes (9, 10), a laborious technique requiring a large
amount of genomic DNA, PCR-based LOH tests for the
purpose of diagnosis with the use of a number of microsatel-
lite markers and the availability of formalin-fixed patholog-
ic samples are of particular interest (14). Microsatellites are
highly polymorphic repetitive nucleotides that are scattered
throughout the genome. They are inherited stably, are unique
to each individual and have a low inherent mutation rate (15,
20). However, recent assessments on the reliability of PCR-
based microsatellite analysis have shown common artifacts
leading to equivocal findings concerning the LOH profile in
the formalin-fixed pathologic tissues with poor DNA quali-
ty (16-18). In the present study using intact genomic DNA
from frozen tissues, common artifacts in the PCR-based mi-
crosatellite analysis were likely to be related to an admixture
of inherent nonspecific allelic bands caused by the unstable
nature of the microsatellite sequences.
Zachos et al. observed frequent LOH on multiple chromo-
somes in psoriasis patients (8): chromosome 3p24-p21.2
(D3S1478, D31298; 57%), 7p15-q22 (D7S478, D7S519;
28%), and 8p21.1-p11.2 and 8p23 (ANK1, D8S7; 50%).
They suggested that certain candidate genes related to cell
cycle regulation were located in these particular chromosomes
regions, which is similar to that observed in neoplastic disor-
ders (21-23), and that LOH contributed to the development
of human psoriatic lesions. In this study using a set of stable
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Fig. 3. Distribution of the informative heterozygous cases according to the relative allelic ratio in psoriasis and colorectal cancer. The
background relative ratios of the wild-type alleles indicative of PCR noise of microsatellite sequences cluster in a range from 1.0 to 1.5
fold in psoriasis. Most of the unilateral signal alterations that were indicative of a LOH are greater than a cut-off point 1.5 in colorectal
cancer.
N
u
m
b
e
r
 
o
f
 
i
n
f
o
r
m
a
t
i
v
e
m
a
r
k
e
r
s
Relative allelic ratio
N
u
m
b
e
r
 
o
f
 
i
n
f
o
r
m
a
t
i
v
e
m
a
r
k
e
r
s
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Psoriasis Colorectal cancer
3p D3S1298 194-220 24.2-22 72.4 10.3
D3S1478 109-152 21.3-21.2 78.1 18.3
D3S1597 80-100 pter-24.2 83.3 20
D3S1611 277-288 24.2-22 63.6 12.1
8p D8S503 240 22 37.5 55.6
D8S261 128-144 22 30.3 41.2
D8S262 114-128 23 66.7 45
D8S552 180 22 70.4 55.6
D8S1734 100-120 22-21.3 51.6 38.7
9p D9S157 133-149 23-22 66.7 29.2
D9S199 144-164 23 71.9 24.2
D9S200 107-127 21-12 69.7 38.5
D9S270 97 21 63.6 15.2
D9S288 120-140 pter-22 73.3 31.3
Chromo
-some 
Marker Size  (bp) Location
LOH*
(%)
Table 2. The results of microsatellite analysis of colorectal can-
cer (N=33)
Hetero-
zygosity (%) 
*LOH: Loss of heterozygosity.
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-microsatellite markers, a few LOHs were identified on 11
chromosomes tested in psoriasis, whereas colorectal cancers
had multiple LOHs involving an extensive chromosomal
region including the tumor suppressor gene. Nonspecific
alleles in chromosome 8p that were not reproducible in re-
peated PCR were equivocally co-migrated with the repro-
ducible true alleles, which could potentially be misinterpret-
ed as heterozygous micorsatellite alleles and LOH. These
PCR artifacts in the microsatellite markers on chromosome
8p were the same microsatellite markers that were reported
to demonstrate frequent LOH in the previous study (8). Our
results suggest that the previous LOH profiles observed in
psoriatic lesions might originate from PCR artifacts associ-
ated with unstable microsatellite markers.
Happle suggested that LOH was unlikely to be a causative
genetic event for a psoriatic lesion of the common type, be-
cause symmetric involvement of psoriasis was considered to
be a manifestation that originated from a germ cell and would
be difficult to be explained by a LOH occurring in the somat-
ic cells (15, 24). According to the ‘two hits’ theory, two alle-
les of the tumor suppressor genes are functionally inactivat-
ed by two rate-limiting alterations, a point mutation in the
nucleotide sequences and a unilateral chromosomal loss tar-
geting a specific genetic locus (25). The tumor-specific chro-
mosomal loss that is never observed in a normal tissue is
thought to confer a selective growth advantage for clonal ex-
pansion of a single somatic cell. Therefore, a LOH is unlike-
ly to be responsible for psoriasis manifesting as a symmetric
involvement.
Demands for standard guidelines for reliable LOH data are
increasing because ambiguous allelic ratios may be encoun-
tered during PCR-based microsatellite analysis. This study
found that intimately juxtaposed heterozygous alleles were
an important source of a borderline level of a LOH, which
were defined as being non-informative for a LOH. Heterozy-
gous psoriatic cases with two separate alleles demonstrated
borderline-level LOHs in 3 cases, which were likely to be
PCR artifacts when compared with the frequent multiple
LOHs observed in colorectal cancer. Three LOH-positive
psoriasis cases with a diminished signal in each chromosomal
arm were distinguishable from the concurrent LOHs involv-
ing multiple markers on a given chromosomal arm in col-
orectal cancer. The three psoriatic cases with a single LOH
appeared to be caused by equivocal amplifications of the upper
and low alleles by chance. It has been reported that a true
LOH representing a chromosomal loss, which is a major event
in malignant lesions, involves a total or an extensive chromo-
somal arm, rather than an interstitial region of the chromo-
some (26). Therefore, a solo LOH of psoriasis appears to be
a false positive result in association with an imbalanced het-
erozygous amplification of wild-type alleles.
Various DNA quantities and qualities of the microdissect-
ed formalin-fixed paraffin-embedded tissue and normal cell
contamination in the microdissected tumor tissue were con-
sidered to be the sources of erroneous allelic imbalances in-
cluding a borderline or incomplete LOH. In this study, the
unstable nature of the microsatellite markers selected, rather
than genomic DNA sampling, is likely to facilitate the com-
mon PCR artifacts. A set of stable microsatellite markers
exhibited a universal cut-off point (1.5) for a LOH in both
frozen psoriatic lesions and formalin-fixed colorectal cancer
tissues, thus providing the best discrimination between nor-
mal PCR noise and a LOH. Our results indicate that psoria-
sis is not associated with a LOH, which must be scored with
careful attention concerning the false-positive results caused
by error-prone microsatellite markers.
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